Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Danese

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Preventive Cardiology|April 23, 2021
Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United KingdomMark D Danese, Peter Pemberton-Ross, David Catterick, et al.
American Journal of Hematology|August 26, 2009
Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpuraMark D Danese, Karla Lindquist, Michelle Gleeson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2012
Inverse probability weighted least squares regression in the analysis of time-censored cost data: an evaluation of the approach using SEER-MedicareRobert I Griffiths, Michelle L Gleeson, Mark D Danese, et al.
Cancer|August 25, 2010
Estimating recurrences prevented from using trastuzumab in HER-2/neu-positive adjuvant breast cancer in the United StatesMark D Danese, Deepa Lalla, Melissa Brammer, et al.
Journal of Cancer Epidemiology|September 13, 2012
Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-MedicareRobert I Griffiths, Michelle L Gleeson, Joseph Mikhael, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2009
Effect of Epoetin alfa dose changes on hemoglobin and mortality in hemodialysis patients with hemoglobin levels persistently below 11 g/dLBrian D Bradbury, Mark D Danese, Michelle Gleeson, et al.
JAMA|July 24, 1996
Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysisM D Danese, N R Powe, C T Sawin, et al.
European Journal of Pediatrics|March 1, 1997
Thyroid carcinoma in children and adolescentsD Danese, A Gardini, A Farsetti, et al.
BMC Cancer|December 25, 2012
Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-MedicareRobert I Griffiths, Mark D Danese, Michelle L Gleeson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literatureM D Danese, P W Ladenson, C L Meinert, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Preventive Cardiology|April 23, 2021
Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United KingdomMark D Danese, Peter Pemberton-Ross, David Catterick, et al.
American Journal of Hematology|August 26, 2009
Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpuraMark D Danese, Karla Lindquist, Michelle Gleeson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2012
Inverse probability weighted least squares regression in the analysis of time-censored cost data: an evaluation of the approach using SEER-MedicareRobert I Griffiths, Michelle L Gleeson, Mark D Danese, et al.
Cancer|August 25, 2010
Estimating recurrences prevented from using trastuzumab in HER-2/neu-positive adjuvant breast cancer in the United StatesMark D Danese, Deepa Lalla, Melissa Brammer, et al.
Journal of Cancer Epidemiology|September 13, 2012
Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-MedicareRobert I Griffiths, Michelle L Gleeson, Joseph Mikhael, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2009
Effect of Epoetin alfa dose changes on hemoglobin and mortality in hemodialysis patients with hemoglobin levels persistently below 11 g/dLBrian D Bradbury, Mark D Danese, Michelle Gleeson, et al.
JAMA|July 24, 1996
Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysisM D Danese, N R Powe, C T Sawin, et al.
European Journal of Pediatrics|March 1, 1997
Thyroid carcinoma in children and adolescentsD Danese, A Gardini, A Farsetti, et al.
BMC Cancer|December 25, 2012
Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-MedicareRobert I Griffiths, Mark D Danese, Michelle L Gleeson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literatureM D Danese, P W Ladenson, C L Meinert, et al.
Pageof 9